Range Low Price High Price Comment
30 days $172.36 $172.36 Friday, 22nd Dec 2023 RETA stock ended at $172.36. During the day the stock fluctuated 0% from a day low at $172.36 to a day high of $172.36.
90 days $172.32 $172.46
52 weeks $26.26 $172.46

Historical RETA prices

Date Open High Low Close Volume
Sep 07, 2023 $169.56 $170.26 $169.56 $170.15 690 016
Sep 06, 2023 $169.38 $169.77 $169.38 $169.63 318 651
Sep 05, 2023 $168.67 $169.98 $168.67 $169.79 642 411
Sep 01, 2023 $168.90 $169.50 $168.90 $169.26 362 174
Aug 31, 2023 $168.84 $169.26 $168.82 $169.00 550 595
Aug 30, 2023 $169.14 $169.17 $168.67 $168.70 456 492
Aug 29, 2023 $169.19 $169.20 $168.80 $168.88 622 915
Aug 28, 2023 $169.11 $169.30 $168.86 $168.90 645 982
Aug 25, 2023 $169.10 $169.27 $168.82 $169.00 363 142
Aug 24, 2023 $169.20 $169.37 $168.56 $168.75 593 244
Aug 23, 2023 $169.25 $169.48 $169.10 $169.16 508 644
Aug 22, 2023 $169.25 $169.55 $169.09 $169.25 951 601
Aug 21, 2023 $169.50 $169.50 $169.03 $169.24 627 271
Aug 18, 2023 $169.00 $169.34 $168.77 $169.26 707 367
Aug 17, 2023 $168.80 $169.29 $168.63 $169.00 502 869
Aug 16, 2023 $168.96 $169.40 $168.28 $169.06 1 088 295
Aug 15, 2023 $169.00 $169.48 $168.76 $169.13 756 916
Aug 14, 2023 $168.00 $169.74 $168.00 $169.27 1 366 608
Aug 11, 2023 $167.30 $168.00 $167.11 $167.48 338 211
Aug 10, 2023 $167.30 $167.85 $166.99 $167.05 486 577
Aug 09, 2023 $167.48 $168.69 $167.00 $167.11 1 363 541
Aug 08, 2023 $166.70 $167.60 $166.50 $167.16 986 980
Aug 07, 2023 $166.50 $167.09 $166.05 $166.42 1 569 004
Aug 04, 2023 $166.95 $167.21 $166.12 $166.39 670 387
Aug 03, 2023 $166.21 $167.51 $165.86 $167.16 1 152 690
Click to get the best stock tips daily for free!

About RETA

RETA Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated ... RETA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT